Location: Home
  • search
  • go
  • Relate News
  • 1/18/2023Moderna in Active Discussions with China to Supply COVID Vaccines
  • 1/17/2023Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio
  • 1/17/2023Entering J&J's Fiefdom, Luye Wins FDA Approval of Long-acting Schizoph...
  • 1/16/2023The China Imperative for Multinational Companies
  • 1/16/2023Prevalence, Awareness, Treatment and Control of Hypertension in China,...
  • 1/16/2023NMPA Announces Package Insert Revision of Sodium Carbosulfate Formulat...
  • 1/16/2023NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...
  • 1/16/2023CARsgen Thera and Huadong Medicine Forms Commercialization Partnership...
  • 1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022
  • 1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
  • 1/13/2023NHC Issues 2nd Batch of the List of Drugs Subject To Focused State Rat...
  • 1/13/2023AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...
  • 1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
  • 1/13/2023Drug R&D and Product Registration News Digest January 2023 (2)
  • 1/12/2023Information Collection on the 8th VBP Officially Initiated
  • 1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...
  • 1/12/2023Porton Pharma to set up biotech park in Slovenia‘s Menges
  • 1/12/2023MNC Incubators in China (PharmaDJ)
  • 1/12/2023Fosun Sees Surge in Demand from Mainland Chinese for Omicron-focused B...
  • 1/11/2023China NMPA Approved 49 New Drugs in 2022 (PharmCube)
  • 1/11/2023Takeda's EXKIVITY® (mobocertinib) Approved China for Patients with E...
  • 1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...
  • 1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...
  • 1/11/2023Hepalink Invests $60M with TPG Biotechnology fund
  • 1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
  • 1/10/2023Pfzier to Begin Producing Paxlovid in China Thru Local Partner within ...
  • 1/10/2023Pfizer CEO Rules Out Authorizing Paxlovid Generic in China
  • 1/10/2023Viking Thera Sues Ascletis Bio of 'Ruse' to Raid Trade Secrets
  • 1/9/2023Fake Indian COVID-19 Medicines Flood China's Black Market
  • 1/9/2023Pfizer's Negotiation with China for NRDL Listing of Covid Drug Paxlovi...
  • Page:115/775 Total number of articles:23235: [First][<<] [113] [114] [115] [116] [117] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group